BioNTech COVID-19 Vaccine Sets Up >50% Annual Yield With 19%Downside Protection
Updated: Jan 16, 2021
Originally published November 9, 2020
Summary
Pfizer and BioNTech announced a 90% effective vaccine for COVID-19.
Shares are soaring on the news, gaping up from pre-news $90 to current $101.66.
This sets up an option opportunity generating for a > 50% annualized yield rate on net invested cash along with 20% downside protection.
